Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Cash flows from operating activities:    
Net income $ 8,667 $ 46,460
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 25,805 26,006
(Gain) loss on disposal of assets (32) 2,793
Goodwill impairment 31,871  
Stock-based compensation expense 3,830 4,058
Amortization of debt issuance costs 537 545
Benefit for deferred income taxes (2,937) (1,381)
Change in fair value of contingent consideration (47) 630
Forward contract losses (gains), net 2,513 (3,973)
Net investment hedge loss 164  
Other, net 1,202 1,304
(Increase) decrease in:    
Accounts receivable (4,685) (6,533)
Inventories 7,776 (6,674)
Income taxes receivable (2,874) (1,598)
Other current assets (1,382) (3,448)
Other assets 2,613 1,259
Increase (decrease) in:    
Accounts payable 1,387 (5,046)
Accrued expenses and other liabilities 955 6,249
Income taxes payable 3,548 3,363
Other noncurrent liabilities (1,884) (2,386)
Contingent consideration payments in excess of acquisition date fair value   (10,731)
Net cash provided by operating activities 77,027 50,897
Cash flows from investing activities:    
Capital expenditures (7,155) (19,584)
Proceeds from dispositions of equipment 103 124
Cash settlement of forward contracts (1,742) 2,256
Software development costs (227)  
Net cash used in investing activities (9,021) (17,204)
Cash flows from financing activities:    
Borrowings on revolving credit facilities 11,000 107,814
Repayment of borrowings on revolving credit facilities (55,609) (135,750)
Borrowings on long-term non-revolving debt 5,812  
Repayment of borrowings on long-term non-revolving debt (5,905) (4,188)
Proceeds from stock issued 1,027 1,252
Dividends to shareholders (8,660) (8,641)
Payment of contingent consideration liability (830) (7,064)
Other financing activities (1,107) (1,370)
Net cash used in financing activities (54,272) (47,947)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3,414) 4,482
Net increase (decrease) in cash, cash equivalents and restricted cash 10,320 (9,772)
Cash, cash equivalents and restricted cash, beginning of period 22,162 23,515
Cash, cash equivalents and restricted cash, end of period $ 32,482 $ 13,743